Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
acknowledged, acknowledging, advocacy, ahead, Anokion, argument, attachment, Attorney, autoantigen, autoreactive, Avery, BB, Bellin, beneficiary, binary, biopharma, birth, Calypso, cap, Catlin, CE, charitable, Chauche, cite, cited, CMAX, complaint, compliant, compliantly, conceptual, Consortium, copay, counsel, CRL, Dear, decree, delegated, dining, dismissed, District, Division, Doherty, EMDAC, Endocrinologic, ERP, ethnic, exceeded, Excellence, fall, FCA, fourteen, fractional, freestanding, Geometric, gradually, greatly, guaranty, guselkumab, Hansa, Hope, House, ID, incentivize, infinity, injunction, instructed, intercompany, isolated, John, juncture, liable, licensure, longstanding, lot, marker, misconduct, month, motion, multiplying, Nancy, NICE, nodal, obexelimab, occupancy, OOPD, ordesekimab, outset, overcharged, partly, passage, peer, physicochemical, physiochemical, pioneer, Pisano, plaintiff, poorly, popPK, postpone, postponed, practitioner, prioritization, prudently, question, qui, racial, Reauthorization, reauthorized, recapture, reconsider, relocate, Rescue, reset, resource, restructuring, resubmission, resumption, runway, SAPHNELO, Scottish, Sean, Selecta, seroconversion, settle, shop, sixty, Society, standalone, stemming, stipulation, Stratification, substudy, subtitle, supervisory, supplementary, Takeda, talent, tam, TDP, Thierry, timeline, treble, TREMFYA, true, tying, undiagnosed, unmanaged, unnecessary, unregistered, USPTO, VNT, voluntarily, warehousing, Wayne, withdrew, Wysenski
Removed:
adjusting, affiliated, allocating, alpha, API, attributable, bridge, careful, CDAI, classification, colonic, colony, converted, Cour, diverted, earn, elicit, endoscopic, EU, excessive, expert, footnote, HL, Hodgkin, illiquid, incipient, instrument, intervening, Intrexon, marketability, myeloid, ninety, Nonemployee, nonexclusive, ordinary, outlined, payroll, prevailing, PvP, PWERM, reclassified, redemption, remeasured, revalued, stimulating, toxic, Trump, UC, underdeveloped, upregulated, uptake, Vaccinology
Filing tables
Filing exhibits
Related press release
Associated PRVB transcripts
PRVB similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Provention Bio, Inc. on Form S-3 (No(s). 333-252045 and 333-232995) and Form S-8 (No(s). 333-249869, 333-237113, 333-230400, 333-226814 and 333-253657) of our report dated February 24, 2022, on our audits of the consolidated financial statements as of December 31, 2021 and 2020 and for each of the years in the three-year period ended December 31, 2021, which report is included in this Annual Report on Form 10-K to be filed on or about February 24, 2022.
/s/ EisnerAmper LLP | |
EISNERAMPER LLP | |
Iselin, New Jersey | |
February 24, 2022 |